Koo J - Search Results

1

A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.

Lebwohl M, Sherer D, Washenik K, Krueger GG, Menter A, Koo J, Feldman SR. Lebwohl M, et al. Among authors: koo j. Int J Dermatol. 2002 May;41(5):269-74. doi: 10.1046/j.1365-4362.2002.01431.x. Int J Dermatol. 2002. PMID: 12100701 Clinical Trial.

2

Topical therapy for psoriasis.

Lebwohl M, Abel E, Zanolli M, Koo J, Drake L. Lebwohl M, et al. Among authors: koo j. Int J Dermatol. 1995 Oct;34(10):673-84. Int J Dermatol. 1995. PMID: 8537153 Review. No abstract available.

3

Cyclosporine as maintenance therapy in patients with severe psoriasis.

Shupack J, Abel E, Bauer E, Brown M, Drake L, Freinkel R, Guzzo C, Koo J, Levine N, Lowe N, McDonald C, Margolis D, Stiller M, Wintroub B, Bainbridge C, Evans S, Hilss S, Mietlowski W, Winslow C, Birnbaum JE. Shupack J, et al. Among authors: koo j. J Am Acad Dermatol. 1997 Mar;36(3 Pt 1):423-32. doi: 10.1016/s0190-9622(97)80219-8. J Am Acad Dermatol. 1997. PMID: 9091474 Free article. Clinical Trial.

4

Cyclosporine consensus conference: with emphasis on the treatment of psoriasis.

Lebwohl M, Ellis C, Gottlieb A, Koo J, Krueger G, Linden K, Shupack J, Weinstein G. Lebwohl M, et al. Among authors: koo j. J Am Acad Dermatol. 1998 Sep;39(3):464-75. doi: 10.1016/s0190-9622(98)70325-1. J Am Acad Dermatol. 1998. PMID: 9738783 Review.

5

A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. OLP302 Study Group.

Koo J. Koo J. Br J Dermatol. 1998 Jul;139(1):88-95. doi: 10.1046/j.1365-2133.1998.02319.x. Br J Dermatol. 1998. PMID: 9764154 Clinical Trial.

6

Cost-effectiveness of methotrexate and Goeckerman therapy: a flawed analysis.

Lim HW, Anderson TF, Douglass M, Koo J, Lebwohl M, Morison W, Taylor C, Zanolli M. Lim HW, et al. Among authors: koo j. Arch Dermatol. 1999 Jun;135(6):717-8. doi: 10.1001/archderm.135.6.717. Arch Dermatol. 1999. PMID: 10376708 No abstract available.

7

Duration of remission of psoriasis therapies.

Koo J, Lebwohl M. Koo J, et al. J Am Acad Dermatol. 1999 Jul;41(1):51-9. doi: 10.1016/s0190-9622(99)70406-8. J Am Acad Dermatol. 1999. PMID: 10411411 Review.

8

Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?

Krueger GG, Feldman SR, Camisa C, Duvic M, Elder JT, Gottlieb AB, Koo J, Krueger JG, Lebwohl M, Lowe N, Menter A, Morison WL, Prystowsky JH, Shupack JL, Taylor JR, Weinstein GD, Barton TL, Rolstad T, Day RM. Krueger GG, et al. Among authors: koo j. J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):281-5. doi: 10.1067/mjd.2000.106374. J Am Acad Dermatol. 2000. PMID: 10906652

9

The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey.

Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. Krueger G, et al. Among authors: koo j. Arch Dermatol. 2001 Mar;137(3):280-4. Arch Dermatol. 2001. PMID: 11255325

10

Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis.

Lebwohl M, Drake L, Menter A, Koo J, Gottlieb AB, Zanolli M, Young M, McClelland P. Lebwohl M, et al. Among authors: koo j. J Am Acad Dermatol. 2001 Oct;45(4):544-53. doi: 10.1067/mjd.2001.116347. J Am Acad Dermatol. 2001. PMID: 11568745 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,557 results

Search Page

Filters